Search results for " malignancy"

showing 2 items of 32 documents

ELS live surgery: a developing story

2019

Since 2015, the European Laryngological Society (ELS) has organized on a yearly basis the European Laryngological Live Surgery Broadcast. The goal of this paper is to demonstrate the increasing worldwide audience. The number of individual computers logged in, number of estimated audience, and number of countries with an active audience were calculated and compared to the numbers in 2015. In 2018, 19 live interventions were performed in three parallel sessions. The surgeons worked in 10 departments in 8 different countries. The number of individual computers logged in increased from 1000 in 2015 to 16000 in 2018. The estimated audience increased from 3000 to 32000 visitors. The number of cou…

medicine.medical_specialtyInternationalityMedical/statistics & numerical dataShort CommunicationPsychological interventionVideo RecordingLaringe MalaltiesBroadcastingLive surgeryPhonosurgeryInternet/statistics & numerical data03 medical and health sciencesOtolaryngology0302 clinical medicineMedicineHumans030223 otorhinolaryngologySocieties MedicalInternetOtorhinolaryngologic Surgical Procedures/statistics & numerical dataCirurgiabusiness.industryGeneral MedicineOtolaryngology/educationSurgeryOtorhinolaryngologic Surgical ProceduresEuropeOtorhinolaryngologyLaryngeal malignancy030220 oncology & carcinogenesisRecurrent respiratory papillomatosisTeaching RoundsTeaching Rounds/methodsbusinessSocietiesSocieties Medical/statistics & numerical dataOïda
researchProduct

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

2019

Background. Management of venous thromboembolism (VTE) in patients with haematologic malignancies and thrombocytopenia is clinically challenging due to the related risks. No prospective studies or clinical trials have been carried out and, therefore, no solid evidence on this compelling issue is available. Methods. Given this, an expert panel endorsed by the Gruppo Italiano Malattie Ematologiche dell'Adulto Working Party on Thrombosis and Haemostasis was set up to produce a formal consensus, according to the RAND method, in order to issue clinical recommendations about the platelet (PLT) cut-off for safe administration of low molecular weight heparin (LMWH) in thrombocytopenic (PLT <100×…

venous thrombosis thrombocytopenia blood cancer anticoagulant treatment consensusanticoagulantsblood cancerblood plateletsvenous thromboembolismthrombocytopeniaHeparin Low-Molecular-Weightheparinplatelet countanticoagulant treatmentSettore MED/15 - MALATTIE DEL SANGUEVenous thromboembolism haematological malignancythrombocytopeniaconsensuslow-molecular-weightOriginal Articlehematologic neoplasmscardiovascular diseasesvenous thrombosishumansanticoagulant treatment; blood cancer; consensus; thrombocytopenia; venous thrombosis; anticoagulants; blood platelets; heparin low-molecular-weight; humans; platelet count; consensus; hematologic neoplasms; thrombocytopenia; venous thromboembolismAnticoagulant treatment; Blood cancer; Consensus; Thrombocytopenia; Venous thrombosis
researchProduct